|
Osmovist 240Drug - Osmovist 240 The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INTRATHECAL
Active Ingredient(s) -
Iotrolan
Strength -
51.3%
Applicant -
BERLEX
New Drug Application (NDA) Number -
019580
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 7, 1989
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Berlex Inc
Osmovist 240
Angio-conray 80% Injectable; Injection
Conray 325 54.3% Injectable; Injection Conray 400 66.8% Injectable; Injection Glofil-125 250-300uci/ml Injectable; Injection Osmovist 190 40.6% Injectable; Intrathecal Osmovist 240 51.3% Injectable; Intrathecal Conray 30 30% Injectable; Injection Conray 43 43% Injectable; Injection Cysto-conray Ii 17.2% Solution; Intravesical Vascoray 52%;26% Injectable; Injection NewDrugInformation |